Articles tagged with Bacterial Pathogens
Tomato plant varieties resistant to bacterial wilt have the ability to restrict bacterial movement in the plant. Researchers discovered that these plants synthesize reinforcement coatings containing ligno-suberin and related phenolic compounds, providing a physico-chemical barrier against pathogen colonization.
Researchers have gained a deeper understanding of how bacteria use the type VI secretion system to develop toxins for battle. The discovery reveals that toxins are encapsulated in a capsule secured by a cork-like plug, which can be released upon mechanical force.
Researchers discovered a signaling mechanism allowing intracellular bacteria like Salmonella to outmaneuver host defenses. By triggering macrophage death and activating the complement system, these bacteria can safely deliver themselves into another macrophage. This 'hack' enables them to persist within infected hosts.
Scientists at Washington State University have discovered a novel theory that the innate immune system can respond differently to specific pathogens. This quality, known as immunological specificity, is driven by the nervous system and could provide a basis for finetuning an experimental treatment to fight infection.
Researchers at the University of Tokyo have developed a cost-effective and convenient method to apply an antimicrobial silver coating to textiles using polyphenols found in wine and chocolate. The coating maintains its properties even after multiple washes and has potential applications in hospitals and other sterile environments.
A new study reveals that the fungus Rhizopus partners with a bacteria called Ralstonia to evade immune cells and predators in soil. This partnership strategy is also used by humans' own immune cells, allowing Rhizopus to cause disease in humans.
Researchers at San Diego State University have discovered a novel way bacteria infect cells by producing long threads, which grows up to 100 times the size of a bacterium in 30 hours. This mechanism allows the bacteria to rapidly infect multiple cells and access more nutrients for growth.
A recent study found that cover cropping can reduce the population of Pseudomonas syringae, a common bacterial pathogen affecting agricultural crops. The researchers also discovered an increase in beneficial microbes such as Sphingomonas and Methylobacterium, which have been used as biocontrol agents against pathogens.
A new genomics study has helped guide the development of vaccines against Shigella, a leading cause of severe diarrhoea in children. The research revealed the extent of genomic diversity among Shigella species, highlighting challenges to current vaccine approaches.
A new standardised test has been developed to accurately determine the transmission of VREfm, enabling rapid identification of potential outbreaks and early intervention. The framework uses genomic analysis to compare bacterial genomes and infer transmission links, facilitating global deployment for outbreak detection and investigation.
Researchers at TTUHSC developed novel hydrophilic nanoparticles that target bacterial membranes, killing pathogens while sparing mammalian cells. The nanoantibiotics' size-dependent activity reveals a new blueprint for developing non-toxic and environmentally friendly antibiotics.
Researchers found that smart windows with dynamic tinting can completely disinfect surfaces within 24 hours, reducing bacterial growth rates and viability. In contrast, traditional windows with blinds blocked almost all daylight, promoting contamination on glass, plastic, and fabric surfaces.
Researchers have discovered that living filtration membranes made from kombucha cultures can resist fouling and maintain faster filtering rates compared to conventional polymer membranes. This breakthrough could lead to an inexpensive, biodegradable, and effective way to treat water, tackling issues such as biofilm formation and clogging.
Rice University researchers developed a microfluidic platform to analyze how infectious bacteria evolve resistance to antibiotics. The platform allows for controlled environments and fine-tuning of conditions, revealing previously unknown pathways to resistance.
Researchers found that half of Pseudomonas syringae strains benefited from the presence of aphids, but only the honeydew itself boosted bacterial populations. The study suggests using this phenomenon to develop alternative pest control methods.
Researchers found that inhibiting gasdermin D, a protein involved in septic patients' organ lesions, can prevent multiple-organ damage and improve prognosis. Disulfiram, a drug originally indicated for alcohol dependence, was shown to inhibit gasdermin D and reduce tissue injury.
A new study by the University of Exeter reveals two previously unknown Vibrio species in UK waters, which can cause gastroenteritis and skin infections in humans. The increasing range of these bacteria also threatens marine biodiversity and the seafood industry, with potential economic costs estimated at £6 billion annually.
A recent study by researchers at Case Western Reserve University found that Candida tropicalis fungus can trigger chronic inflammation in the gut microbiome of Crohn's disease patients. This imbalance of fungi and bacteria can create a predisposition to inflammatory bowel disease.
Researchers have discovered a molecular mechanism that contributed to the emergence of the seventh cholera pandemic. The study found that modified Vibrio cholerae bacteria used their type 6 secretion system (T6SS) to outcompete and kill older strains, leading to their displacement.
Researchers found three protective cultures effective against Listeria monocytogenes, which can cause life-threatening listeriosis. These cultures disrupt pathogen survival and attachment to cells, making them a promising solution for cheese producers.
A new study reveals that Xanthomonas euvesicatoria has evolved to evade the immune system of tomato plants by changing a single amino acid in its flagellin proteins. This finding poses significant challenges for breeding disease-resistant tomato varieties, forcing farmers to rely on fungicides and copper treatments.
New research combines antibiotics and phage therapy to cure infections more effectively and reduce antibiotic use. The study found that bacteriostatic antibiotics trigger CRISPR-Cas adaptive immunity in bacteria, increasing the chances of treatment efficacy.
Researchers at the University of Copenhagen have discovered that resistant bacteria can hide resistance genes in inactive bacteria within biofilms, creating a reservoir of resistance that can be drawn upon when antibiotics are not present. This new understanding challenges the long-held assumption that resistant bacteria lose their res...
Researchers identified 'pre-resistance' signs in bacteria, predicting future resistance to antibiotics. This discovery allows doctors to select the best treatments for bacterial infections and paves the way for personalized genomic therapy.
Scientists have measured the speed of Candidatus Liberibacter asiaticus, a bacterium causing citrus greening disease. The bacteria can colonize a tree in around 80-100 days, faster than symptoms appear, making it difficult to control.
Research at University of Basel discovered that certain areas in tissue allow bacteria to survive despite antibiotic therapy. Immune system plays a critical role in eradicating bacteria, and boosting defenses with immune therapy can lead to more effective clearance.
A study of Edo-era Japanese skeletons reveals a prevalence of periodontal disease similar to modern times, with distinct bacterial species. Researchers analyzed dental calculus from 12 human skeletons and compared their oral microbiomes to modern samples, shedding light on the evolution of the oral microbiome.
Scientists have developed an enzyme that degrades the capsule surrounding the bacterium that causes anthrax, reducing virulence and protecting mice from infection. The treatment, known as PEG-CapD-CPS334C, is a promising avenue for treating multidrug-resistant anthrax and other bacterial infections.
A recent study uses machine learning to rapidly discover bacterial isolates with antifungal properties, identifying promising new compounds for crop protection. The approach analyzes thousands of microbial genomes at once, allowing researchers to identify novel beneficial microbes and bypass traditional screening tactics.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A study found that long-term cannabis smokers have increased levels of Actinomyces meyeri in their saliva, which correlates with the length of cannabis use. This bacterium was shown to decrease activity and increase beta-amyloid production in mice, suggesting a link between oral microbiome disruption and brain health.
Scientists at Virginia Tech have identified a critical modification in the protective molecular bag of the Lyme disease-causing bacterium, allowing it to move effectively and cause disease. The discovery, published in Nature Microbiology, reveals that the bacteria acquires this unique sugar modification from ticks.
Scientists have studied how different drugs affect Pseudomonas aeruginosa, revealing what makes it resistant to antibiotics. A new experimental substance called CHIR-090 has shown promise in blocking the production of sugar-lipid compounds, a previously unexploited target for treatment.
Researchers from Trinity College Dublin investigate the epidemiology and population biology of Enteroccocus faecium, a high-priority pathogen. They found that Irish isolates have evolved independently and are diverse, with a unique genetic transposon element encoding vancomycin resistance.
Researchers have discovered a specific type of gut bacteria in bees that can improve memory, with bumblebees showing enhanced memory when fed this bacteria. The study suggests a causal link between the gut microbiome and cognitive abilities, opening up possibilities for similar effects in humans.
Scientists have clarified phytochrome's atomic-scale resolution, unlocking its role in regulating bacterial pathogenicities. The study provides a new photoactivation model explaining the signaling mechanism of black rot disease.
Researchers at the University of Alabama at Birmingham discovered the mechanism of secretion and trafficking of Mycobacterium tuberculosis' toxin TNT, which kills over 1 million people annually. The ESX-4 type VII secretion system plays a crucial role in transporting TNT across cell membranes.
Researchers at Massachusetts General Hospital have uncovered important details about Shigella's translocon, a pore that injects bacterial proteins into infected cells. The findings may help develop an effective strategy to block this critical component of infection and prevent diseases like dysentery.
Researchers discovered that these 'meat-eating' bees have a unique gut microbiome enriched with acid-loving bacteria, similar to those found in vultures. The bees' ability to eat dead bodies is surprising, but they can also store honey and have special chambers for meat storage.
A study by Weill Cornell Medicine investigators found that antibodies secreted in the gut help control pathogenic forms of gut fungi like Candida albicans. However, patients with Crohn's disease often have impaired antibody function, leading to an overgrowth of harmful fungi.
Researchers at Harvard's Wyss Institute have developed a microfluidic Organ Chip device that accurately models cystic fibrosis lung airway pathology. The model replicates key pathological hallmarks, including mucus layer changes and inflammatory responses, providing a comprehensive preclinical human model for investigating new therapies.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
Scientists at the Max Planck Institute have uncovered how ExoY toxin becomes activated in human cells by binding to actin filaments, leading to devastating enzymatic activity. This discovery sheds light on a crucial molecular mechanism that underlies the pathogenicity of various toxins.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
Scientists used computational strategies to evaluate antibiotic candidates, identifying a promising new variant that is up to 56 times more active than existing antibiotics. This approach enables faster and more affordable development of new antibiotics, helping to combat resistance.
A new technique measures bacterial metabolic activity with an electric probe to identify antibiotic resistance in less than 90 minutes. This rapid method enables doctors to quickly determine which antibiotics will or won't work for a patient's infection, improving treatment decisions and potentially saving lives.
A global review found bioaerosols can be transmitted throughout a building by defective plumbing and that opening toilet lids after flushing disperses contaminated droplets. Uncovered rubbish bins and poor surface cleaning also contribute to high bacterial loads.
A new study reveals that iboxamycin effectively fights both gram-negative and gram-positive drug-resistant bacteria in mouse models. The researchers discovered the molecular mechanism that allows this drug to overcome resistance, which is important for developing new antibiotics.
Recent studies have shed light on the activation of pattern recognition receptors during infection with obligate intracellular bacteria. The authors summarize the clinical features of these infections and discuss recent advances in host recognition, highlighting knowledge gaps in understanding innate immunity.
Chromobacterium violaceum uses zinc ion transporter ZnuABC to overcome host constraints on metal availability, increasing its virulence. The discovery offers a route for novel therapies against bacterial infections.
A large-scale study characterized 585 strains of the Xanthomonas perforans bacterium in Florida commercial tomato fields, finding associations between farms and transplant facilities as key points of pathogen spread. This research provides insights into the diversity of the pathogen population and potential control strategies for farmers.
Researchers at Cornell University used machine learning to predict the spread of antibiotic resistance genes among bacteria, identifying potential networks of exchange and driving factors. The approach could help control the spread of antibiotic resistance and develop new targets for novel antibiotics.
Researchers identified a bacterium on healthy cats that produces antibiotics against severe skin infections in humans and pets. The discovery may lead to new treatments for MRSP infections in dogs and potentially other inflammatory skin diseases.
Researchers found that Pseudomonas aeruginosa populations in CF patients' sinuses vary widely, with evolution following two stages: pathoadaptive community formation and fragmentation. This discovery may inform new therapeutic approaches by focusing on strongest evolutionary pressures.
Researchers found that environmental factors and genetic traits contribute to the emergence of deadly variants of Vibrio vulnificus, a flesh-eating bacterium. The study's findings could help create a model for other human pathogens.
Researchers at the University of Oklahoma have contributed to a study on a new antibiotic that may cure Lyme disease and eradicate its occurrence from the environment. The antibiotic, hygromycin A, targets the ribosomes of the bacteria Borrelia burgdorferi and shows promise in treating the disease.
Researchers have successfully used double-stranded RNA (dsRNA) molecules as a bio-fungicide to suppress the production of a toxin in soybean plants. The study found that dsRNAs produced in bacterial cells can effectively manage fungal diseases, reducing the need for toxic chemicals and potentially mitigating fungicide resistance.
Researchers from EMBL Heidelberg and University of Tübingen discovered that certain antibiotics, like tetracyclines and macrolides, can kill specific gut microbes. Combining antibiotics with non-antibiotic drugs may reduce collateral damage by preserving antibiotic activity against pathogens.
Researchers found that nanosilver treatment can increase the risk of recurrent infections when used long-term due to pathogen adaptation. Long-term exposure allows bacteria like Pseudomonas aeruginosa to evolve and resume normal growth upon discontinuation of treatment.